Fitch Affirms Express Scripts IDR at 'BBB'; Outlook Revised to Stable
Fitch Ratings has affirmed the Issuer Default Ratings (IDRs) of Express
Scripts Holdings (NYSE: ESRX) and its subsidiaries (Express Scripts,
Inc. and Medco Health Solutions, Inc. [MHS]) at 'BBB'. The ratings apply
to roughly $15.7 billion in debt, and Fitch has revised the Rating
Outlooks for all three IDRs to Stable from Negative. A complete list of
ESRX's ratings can be found at the end of this press release.
Key Rating Drivers:
--The Stable Outlook acknowledges that ESRX's current leverage measured
as total debt-to-EBITDA remains high for the company's 'BBB' rating, as
a result the Medco Health, Inc. (Medco) acquisition in April 2012.
--Fitch, however, expects that ESRX